Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) Return on Sales (2023 - 2024)

Contineum Therapeutics has reported Return on Sales over the past 2 years, most recently at 0.38% for Q1 2024.

  • Quarterly results put Return on Sales at 0.38% for Q1 2024, down 5205.0% from a year ago — trailing twelve months through Mar 2024 was 0.38% (changed N/A YoY), and the annual figure for FY2023 was 0.45%, changed.
  • Return on Sales for Q1 2024 was 0.38% at Contineum Therapeutics, down from 0.46% in the prior quarter.
  • Over the last five years, Return on Sales for CTNM hit a ceiling of 52.43% in Q1 2023 and a floor of 0.38% in Q1 2024.